Host Gene Regulation by Transposable Elements: the New, the Old and the Ugly

Total Page:16

File Type:pdf, Size:1020Kb

Load more

viruses Review Host Gene Regulation by Transposable Elements: The New, the Old and the Ugly Rocio Enriquez-Gasca y , Poppy A. Gould y and Helen M. Rowe * Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London E1 2AT, UK; [email protected] (R.E.-G.); [email protected] (P.A.G.) * Correspondence: [email protected] These authors contributed equally to this paper. y Received: 17 August 2020; Accepted: 23 September 2020; Published: 26 September 2020 Abstract: The human genome has been under selective pressure to evolve in response to emerging pathogens and other environmental challenges. Genome evolution includes the acquisition of new genes or new isoforms of genes and changes to gene expression patterns. One source of genome innovation is from transposable elements (TEs), which carry their own promoters, enhancers and open reading frames and can act as ‘controlling elements’ for our own genes. TEs include LINE-1 elements, which can retrotranspose intracellularly and endogenous retroviruses (ERVs) that represent remnants of past retroviral germline infections. Although once pathogens, ERVs also represent an enticing source of incoming genetic material that the host can then repurpose. ERVs and other TEs have coevolved with host genes for millions of years, which has allowed them to become embedded within essential gene expression programmes. Intriguingly, these host genes are often subject to the same epigenetic control mechanisms that evolved to combat the TEs that now regulate them. Here, we illustrate the breadth of host gene regulation through TEs by focusing on examples of young (The New), ancient (The Old), and disease-causing (The Ugly) TE integrants. Keywords: gene regulation; transposable elements; endogenous retroviruses; epigenetic repression; Intracisternal A-type particle elements; position-effect variegation; KRAB-associated protein 1; X chromosome inactivation; genomic imprinting 1. Introduction In contrast to their paramount functional importance, protein-coding genes constitute only a small fraction (~2–4%) of the total DNA sequence of the human genome. Exquisitely regulated control of coding genes in time and space is a defining feature of development of multi-cellular organisms. For example, transcription can be regulated by the generation of multiple isoforms of the same gene by alternative splicing, alternative promoter/enhancer usage, non-coding RNAs and epigenetic modifications, which control chromatin structure and function (reviewed in [1]). On the other hand transposable elements (TEs) constitute an estimated two thirds of the human genome [2,3], and contribute to the regulation of protein-coding genes through their regulatory elements. TEs exercise a complex dialog with their host genomes that is distinct from a conventional virus-host arms race because they are not only potential parasites, but also a vital source of genome innovation [4–8]. TEs are subject to epigenetic silencing by histone modifications and DNA methylation [9–11] and become mutated and inactive over the course of evolution. A fraction, however, are co-opted and preserved under purifying selection. In this review, we illustrate how TEs have been co-opted to regulate host genes by focusing on TEs that can alter their surrounding epigenetic context, with our goal to highlight TEs as a normal feature of host gene regulation. The fact that TEs are so ubiquitous in the genome, contain their own Viruses 2020, 12, 1089; doi:10.3390/v12101089 www.mdpi.com/journal/viruses Viruses 2020, 12, 1089 2 of 21 Viruses 2020, 12, x FOR PEER REVIEW 2 of 21 regulatory sequences and have become hotbeds of epigeneticepigenetic regulatory marks, due to theirtheir initialinitial transcriptional silencing, means that they are ideally ideally placed placed to to re-shape re-shape host host gene gene expression expression profiles. profiles. We willwill journeyjourney backback inin timetime toto exploreexplore firstfirst howhow youngyoung oror ‘new’‘new’ TEs, followed by ‘old’ TEs regulate mammalian genes. New TEs are here defineddefined as specificspecific to the primateprimate or murinemurine lineage,lineage, whereas old TEs correspond to those which predate thethe splitsplit betweenbetween mousemouse andand humanhuman ancestralancestral lineageslineages (see(see Figure Figure 1 for examples examples selected selected in in this this review). review). This This distinction distinction allows allows us to us emphasize to emphasize that, while that, whilegene regulatory gene regulatory mechanisms mechanisms involving involving TEs are TEs generally are generally conserved conserved across across species, species, the precise the precise TEs TEsthat thatrewire rewire genes genes are often areoften species-specific. species-specific. This is This due isto duethe different to the di ffTEerent invasions TE invasions that each that species each specieshas encountered. has encountered. We finally We finallyreview reviewinstances instances whereb wherebyy ‘ugly’ ‘ugly’TEs have TEs been have retained been retained by the by host the hostgenome, genome, likely likely due to due them to being them beingbeneficial, beneficial, as well as as well potentially as potentially detrimental detrimental and therefore and therefore discuss discussthe risk thethat risk TE thatco-option TE co-option poses. poses. Figure 1.1. Evolutionary map of example co-opted transp transposableosable elements (TEs) (TEs) for for gene regulation. Clade diagram of of human human and and mouse mouse evolutionary evolutionary traj trajectoriesectories overlaid overlaid with with bubble bubble plots plots showing showing the therelative relative prevalence prevalence of all of allTEs TEs in inthe the human human (blu (blue)e) and and mouse mouse (green) (green) genomes, genomes, according according to their taxonomic specificityspecificity (from(from thethe Dfam database of repetitive DNA families). The dotted line represents an arbitraryarbitrary evolutionaryevolutionary timetime cutocutoffff to to classify classify TEs TEs as as ‘Old’ ‘Old’ vs. vs. ‘New’ ‘New’ in in this this review. review. TEs TEs discussed discussed in thisin this review review are are annotated annotated within within their their respective respective taxa taxa and and colour colour coded coded according according toto theirtheir TETE classclass (see(see thethe key). key). ERV; ERV; endogenous endogenous retrovirus, retrovirus, LINE; longLINE; interspersed long interspersed elements; SINE;elements; short SINE; interspersed short elements,interspersed SVA; elements, SINE/VNTR SVA;/ AluSINE/VNTR/Alu elements. elements. 2. Gene Regulation by Transposable Elements: The New 2. Gene Regulation by Transposable Elements: The New Since the human and mouse lineages diverged from a common ancestor around 80 million years Since the human and mouse lineages diverged from a common ancestor around 80 million years ago, their genomes have been subject to different selective pressures, innovations and invasions. ago, their genomes have been subject to different selective pressures, innovations and invasions. The The present-day human genome has been found to contain no endogenous retroviruses (ERVs) capable present-day human genome has been found to contain no endogenous retroviruses (ERVs) capable of replication/transposition [12], but to host around 100 retrotransposition competent Long INterspersed of replication/transposition [12], but to host around 100 retrotransposition competent Long Element 1s (LINE-1s or L1s) [13]. The human genome is also home to SVA elements, a newly evolved INterspersed Element 1s (LINE-1s or L1s) [13]. The human genome is also home to SVA elements, a newly evolved composite TE derived from SINEs and an ERV (HERV-K10). SVAs harbour a variable number of tandem repeats (VNTRs) and hijack L1 retrotransposition machinery for their Viruses 2020, 12, 1089 3 of 21 Viruses 2020, 12, x FOR PEER REVIEW 3 of 21 composite TE derived from SINEs and an ERV (HERV-K10). SVAs harbour a variable number of tandemmobilisation. repeats With (VNTRs) the youngest and hijack SVA L1 family retrotransposition (SVA_F), around machinery three for million their mobilisation.years old (myo), With SVA the youngestelements SVArepresent family the (SVA_F), youngest around TE in three the huma millionn genome years old [14]. (myo), In contrast, SVA elements the mouse represent genome the youngestappears to TE contain in the humancohorts genome of ERVs [ 14and]. InL1s contrast, capable the of mouseretrotransposition genome appears [15,16]. to containHere, we cohorts inspect of ERVsexamples and L1sof epigenetic capable of retrotranspositioncontrol of host genes [15,16 through]. Here, weregulatory inspect examplessequences of embedded epigenetic controlin young of hostspecies-specific genes through TEs. regulatory We draw sequences on mouse embedded and huma inn youngexamples species-specific and discuss TEs.how Wethis draw can shape on mouse our andunderstanding human examples of how and TEs discuss underpin how human this can adaptati shape ouron and understanding genetic variation. of how We TEs include underpin scenarios human adaptationwhereby parallel and genetic TEs have variation. been Weindependently include scenarios co-opted whereby for the parallel same TEspurpose have beenin both independently organisms. co-optedFuture studies for the on same actively purpose transposing in both TEs organisms. may allow Future us to studies observe on how actively genome transposing invaders TEs become may allowco-opted us
Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture

    Analysis of Trans Esnps Infers Regulatory Network Architecture

    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
  • Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis

    Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis

    Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma, Anna-Karin Ekman, Cecilia Bivik Eding and Charlotta Enerbäck The self-archived postprint version of this journal article is available at Linköping University Institutional Repository (DiVA): http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-147791 N.B.: When citing this work, cite the original publication. Verma, D., Ekman, A., Bivik Eding, C., Enerbäck, C., (2018), Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis, Journal of Investigative Dermatology, 138(5), 1088-1093. https://doi.org/10.1016/j.jid.2017.11.036 Original publication available at: https://doi.org/10.1016/j.jid.2017.11.036 Copyright: Elsevier http://www.elsevier.com/ Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma*a, Anna-Karin Ekman*a, Cecilia Bivik Edinga and Charlotta Enerbäcka *Authors contributed equally aIngrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Division of Dermatology, Linköping University, Linköping, Sweden Corresponding author: Charlotta Enerbäck Ingrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Linköping University SE-581 85 Linköping, Sweden Phone: +46 10 103 7429 E-mail: [email protected] Short title Differential methylation in psoriasis Abbreviations CGI, CpG island; DMS, differentially methylated site; RRBS, reduced representation bisulphite sequencing Keywords (max 6) psoriasis, epidermis, methylation, Wnt, susceptibility, expression 1 ABSTRACT Psoriasis is a chronic inflammatory skin disease with both local and systemic components. Genome-wide approaches have identified more than 60 psoriasis-susceptibility loci, but genes are estimated to explain only one third of the heritability in psoriasis, suggesting additional, yet unidentified, sources of heritability.
  • TASOR Is a Pseudo-PARP That Directs HUSH Complex Assembly and Epigenetic Transposon Control

    TASOR Is a Pseudo-PARP That Directs HUSH Complex Assembly and Epigenetic Transposon Control

    Lawrence Berkeley National Laboratory Recent Work Title TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control. Permalink https://escholarship.org/uc/item/6021r2cd Journal Nature communications, 11(1) ISSN 2041-1723 Authors Douse, Christopher H Tchasovnikarova, Iva A Timms, Richard T et al. Publication Date 2020-10-02 DOI 10.1038/s41467-020-18761-6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California ARTICLE https://doi.org/10.1038/s41467-020-18761-6 OPEN TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control Christopher H. Douse 1,4,9, Iva A. Tchasovnikarova2,5,9, Richard T. Timms 2,9, Anna V. Protasio 2,6, Marta Seczynska2, Daniil M. Prigozhin 1,7, Anna Albecka1,2,8, Jane Wagstaff3, James C. Williamson2, ✉ ✉ Stefan M. V. Freund3, Paul J. Lehner 2 & Yorgo Modis 1,2 1234567890():,; The HUSH complex represses retroviruses, transposons and genes to maintain the integrity of vertebrate genomes. HUSH regulates deposition of the epigenetic mark H3K9me3, but how its three core subunits — TASOR, MPP8 and Periphilin — contribute to assembly and targeting of the complex remains unknown. Here, we define the biochemical basis of HUSH assembly and find that its modular architecture resembles the yeast RNA-induced tran- scriptional silencing complex. TASOR, the central HUSH subunit, associates with RNA pro- cessing components. TASOR is required for H3K9me3 deposition over LINE-1 repeats and repetitive exons in transcribed genes. In the context of previous studies, this suggests that an RNA intermediate is important for HUSH activity. We dissect the TASOR and MPP8 domains necessary for transgene repression.
  • Noelia Díaz Blanco

    Noelia Díaz Blanco

    Effects of environmental factors on the gonadal transcriptome of European sea bass (Dicentrarchus labrax), juvenile growth and sex ratios Noelia Díaz Blanco Ph.D. thesis 2014 Submitted in partial fulfillment of the requirements for the Ph.D. degree from the Universitat Pompeu Fabra (UPF). This work has been carried out at the Group of Biology of Reproduction (GBR), at the Department of Renewable Marine Resources of the Institute of Marine Sciences (ICM-CSIC). Thesis supervisor: Dr. Francesc Piferrer Professor d’Investigació Institut de Ciències del Mar (ICM-CSIC) i ii A mis padres A Xavi iii iv Acknowledgements This thesis has been made possible by the support of many people who in one way or another, many times unknowingly, gave me the strength to overcome this "long and winding road". First of all, I would like to thank my supervisor, Dr. Francesc Piferrer, for his patience, guidance and wise advice throughout all this Ph.D. experience. But above all, for the trust he placed on me almost seven years ago when he offered me the opportunity to be part of his team. Thanks also for teaching me how to question always everything, for sharing with me your enthusiasm for science and for giving me the opportunity of learning from you by participating in many projects, collaborations and scientific meetings. I am also thankful to my colleagues (former and present Group of Biology of Reproduction members) for your support and encouragement throughout this journey. To the “exGBRs”, thanks for helping me with my first steps into this world. Working as an undergrad with you Dr.
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT

    WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
  • Download Author Version (PDF)

    Download Author Version (PDF)

    Molecular BioSystems Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/molecularbiosystems Page 1 of 29 Molecular BioSystems Mutated Genes and Driver Pathways Involved in Myelodysplastic Syndromes—A Transcriptome Sequencing Based Approach Liang Liu1*, Hongyan Wang1*, Jianguo Wen2*, Chih-En Tseng2,3*, Youli Zu2, Chung-che Chang4§, Xiaobo Zhou1§ 1 Center for Bioinformatics and Systems Biology, Division of Radiologic Sciences, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA. 2 Department of Pathology, the Methodist Hospital Research Institute,
  • HHS Public Access Author Manuscript

    HHS Public Access Author Manuscript

    HHS Public Access Author manuscript Author Manuscript Author ManuscriptJAMA Psychiatry Author Manuscript. Author Author Manuscript manuscript; available in PMC 2015 August 03. Published in final edited form as: JAMA Psychiatry. 2014 June ; 71(6): 657–664. doi:10.1001/jamapsychiatry.2014.176. Identification of Pathways for Bipolar Disorder A Meta-analysis John I. Nurnberger Jr, MD, PhD, Daniel L. Koller, PhD, Jeesun Jung, PhD, Howard J. Edenberg, PhD, Tatiana Foroud, PhD, Ilaria Guella, PhD, Marquis P. Vawter, PhD, and John R. Kelsoe, MD for the Psychiatric Genomics Consortium Bipolar Group Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis (Nurnberger, Koller, Edenberg, Foroud); Institute of Psychiatric Research, Department of Psychiatry, Indiana University School of Medicine, Indianapolis (Nurnberger, Foroud); Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism Intramural Research Program, Bethesda, Maryland (Jung); Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis (Edenberg); Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, School of Medicine, University of California, Irvine (Guella, Vawter); Department of Psychiatry, School of Medicine, Corresponding Author: John I. Nurnberger Jr, MD, PhD, Institute of Psychiatric Research, Department of Psychiatry, Indiana University School of Medicine, 791 Union Dr, Indianapolis, IN 46202 ([email protected]). Author Contributions: Drs Koller and Vawter had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Nurnberger, Koller, Edenberg, Vawter. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Nurnberger, Koller, Jung, Vawter.
  • A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants

    A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants

    A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Lars G. Fritsche1†, Wilmar Igl2†, Jessica N. Cooke Bailey3†, Felix Grassmann4†, Sebanti Sengupta1†, Jennifer L. Bragg-Gresham1,5, Kathryn P. Burdon6, Scott J. Hebbring7, Cindy Wen8, Mathias Gorski2, Ivana K. Kim9, David Cho10, Donald Zack11,12,13,14,15, Eric Souied16, Hendrik P. N. Scholl11,17, Elisa Bala18, Kristine E. Lee19, David J. Hunter20,21, Rebecca J. Sardell22, Paul Mitchell23, Joanna E. Merriam24, Valentina Cipriani25,26, Joshua D. Hoffman27, Tina Schick28, Yara T. E. Lechanteur29, Robyn H. Guymer30, Matthew P. Johnson31, Yingda Jiang32, Chloe M. Stanton33, Gabriëlle H. S. Buitendijk34,35, Xiaowei Zhan1,36,37, Alan M. Kwong1, Alexis Boleda38, Matthew Brooks39, Linn Gieser38, Rinki Ratnapriya38, Kari E. Branham39, Johanna R. Foerster1, John R. Heckenlively39, Mohammad I. Othman39, Brendan J. Vote6, Helena Hai Liang30, Emmanuelle Souzeau40, Ian L. McAllister41, Timothy Isaacs41, Janette Hall40, Stewart Lake40, David A. Mackey6,30,41, Ian J. Constable41, Jamie E. Craig40, Terrie E. Kitchner7, Zhenglin Yang42,43, Zhiguang Su44, Hongrong Luo8,44, Daniel Chen8, Hong Ouyang8, Ken Flagg8, Danni Lin8, Guanping Mao8, Henry Ferreyra8, Klaus Stark2, Claudia N. von Strachwitz45, Armin Wolf46, Caroline Brandl2,4,47, Guenther Rudolph46, Matthias Olden2, Margaux A. Morrison48, Denise J. Morgan48, Matthew Schu49,50,51,52,53, Jeeyun Ahn54, Giuliana Silvestri55, Evangelia E. Tsironi56, Kyu Hyung Park57, Lindsay A. Farrer49,50,51,52,53, Anton Orlin58, Alexander Brucker59, Mingyao Li60, Christine Curcio61, Saddek Mohand-Saïd62,63,64,65, José-Alain Sahel62,63,64,65,66,67,68, Isabelle Audo62,63,64,69, Mustapha Benchaboune65, Angela J.
  • Whole-Exome Sequencing Identifies Causative Mutations in Families

    Whole-Exome Sequencing Identifies Causative Mutations in Families

    BASIC RESEARCH www.jasn.org Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract Amelie T. van der Ven,1 Dervla M. Connaughton,1 Hadas Ityel,1 Nina Mann,1 Makiko Nakayama,1 Jing Chen,1 Asaf Vivante,1 Daw-yang Hwang,1 Julian Schulz,1 Daniela A. Braun,1 Johanna Magdalena Schmidt,1 David Schapiro,1 Ronen Schneider,1 Jillian K. Warejko,1 Ankana Daga,1 Amar J. Majmundar,1 Weizhen Tan,1 Tilman Jobst-Schwan,1 Tobias Hermle,1 Eugen Widmeier,1 Shazia Ashraf,1 Ali Amar,1 Charlotte A. Hoogstraaten,1 Hannah Hugo,1 Thomas M. Kitzler,1 Franziska Kause,1 Caroline M. Kolvenbach,1 Rufeng Dai,1 Leslie Spaneas,1 Kassaundra Amann,1 Deborah R. Stein,1 Michelle A. Baum,1 Michael J.G. Somers,1 Nancy M. Rodig,1 Michael A. Ferguson,1 Avram Z. Traum,1 Ghaleb H. Daouk,1 Radovan Bogdanovic,2 Natasa Stajic,2 Neveen A. Soliman,3,4 Jameela A. Kari,5,6 Sherif El Desoky,5,6 Hanan M. Fathy,7 Danko Milosevic,8 Muna Al-Saffar,1,9 Hazem S. Awad,10 Loai A. Eid,10 Aravind Selvin,11 Prabha Senguttuvan,12 Simone Sanna-Cherchi,13 Heidi L. Rehm,14 Daniel G. MacArthur,14,15 Monkol Lek,14,15 Kristen M. Laricchia,15 Michael W. Wilson,15 Shrikant M. Mane,16 Richard P. Lifton,16,17 Richard S. Lee,18 Stuart B. Bauer,18 Weining Lu,19 Heiko M. Reutter ,20,21 Velibor Tasic,22 Shirlee Shril,1 and Friedhelm Hildebrandt1 Due to the number of contributing authors, the affiliations are listed at the end of this article.
  • Oncogenic Fusion Protein FGFR2-PPHLN1: Requirements for Biological Activation, and Efficacy of Inhibitors

    Oncogenic Fusion Protein FGFR2-PPHLN1: Requirements for Biological Activation, and Efficacy of Inhibitors

    UC San Diego UC San Diego Previously Published Works Title Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors. Permalink https://escholarship.org/uc/item/12g996rt Journal Translational oncology, 13(12) ISSN 1936-5233 Authors Li, Fangda Meyer, April N Peiris, Malalage N et al. Publication Date 2020-12-01 DOI 10.1016/j.tranon.2020.100853 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Translational Oncology 13 (2020) 100853 Contents lists available at ScienceDirect Translational Oncology journal homepage: www.elsevier.com/locate/tranon Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors ⁎ Fangda Li a, April N. Meyer a, Malalage N. Peiris a, Katelyn N. Nelson a, Daniel J. Donoghue a,b, a Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093-0367, USA b UCSD Moores Cancer Center and Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093-0367, USA ARTICLE INFO ABSTRACT Article history: Aim of study: Chromosomal translocations such as t(10;12)(q26,q12) are associated with intrahepatic cholangiocarci- Received 2 May 2020 noma, a universally fatal category of liver cancer. This translocation creates the oncogenic fusion protein of Fibroblast Received in revised form 24 July 2020 Growth Factor Receptor 2 joined to Periphilin 1. The aims of this study were to identify significant features required for Accepted 9 August 2020 biological activation, analyze the activation of downstream signaling pathways, and examine the efficacy of the TKIs Available online xxxx BGJ398 and TAS-120, and of the MEK inhibitor Trametinib.
  • PPHLN1 Rabbit Pab

    PPHLN1 Rabbit Pab

    Leader in Biomolecular Solutions for Life Science PPHLN1 Rabbit pAb Catalog No.: A17706 Basic Information Background Catalog No. The protein encoded by this gene is one of the several proteins that become sequentially A17706 incorporated into the cornified cell envelope during the terminal differentiation of keratinocyte at the outer layers of epidermis. This protein interacts with periplakin, Observed MW which is known as a precursor of the cornified cell envelope. The cellular localization 53kDa pattern and insolubility of this protein suggest that it may play a role in epithelial differentiation and contribute to epidermal integrity and barrier formation. Multiple Calculated MW alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008] Category Primary antibody Applications WB Cross-Reactivity Human, Mouse, Rat Recommended Dilutions Immunogen Information WB 1:500 - 1:2000 Gene ID Swiss Prot 51535 Q8NEY8 Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 195-255 of human PPHLN1 (NP_958846.1). Synonyms CR;HSPC206;HSPC232;PPHLN1 Contact Product Information 400-999-6126 Source Isotype Purification Rabbit IgG Affinity purification [email protected] www.abclonal.com.cn Storage Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3. Validation Data Western blot analysis of extracts of various cell lines, using PPHLN1 antibody (A17706) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit (RM00020). Exposure time: 10s. Antibody | Protein | ELISA Kits | Enzyme | NGS | Service For research use only.
  • Oncogenic Fusion Protein FGFR2-PPHLN1: Requirements for Biological Activation, and Efficacy of Inhibitors ⁎ Fangda Li A, April N

    Oncogenic Fusion Protein FGFR2-PPHLN1: Requirements for Biological Activation, and Efficacy of Inhibitors ⁎ Fangda Li A, April N

    Translational Oncology 13 (2020) 100853 Contents lists available at ScienceDirect Translational Oncology journal homepage: www.elsevier.com/locate/tranon Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors ⁎ Fangda Li a, April N. Meyer a, Malalage N. Peiris a, Katelyn N. Nelson a, Daniel J. Donoghue a,b, a Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093-0367, USA b UCSD Moores Cancer Center and Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093-0367, USA ARTICLE INFO ABSTRACT Article history: Aim of study: Chromosomal translocations such as t(10;12)(q26,q12) are associated with intrahepatic cholangiocarci- Received 2 May 2020 noma, a universally fatal category of liver cancer. This translocation creates the oncogenic fusion protein of Fibroblast Received in revised form 24 July 2020 Growth Factor Receptor 2 joined to Periphilin 1. The aims of this study were to identify significant features required for Accepted 9 August 2020 biological activation, analyze the activation of downstream signaling pathways, and examine the efficacy of the TKIs Available online xxxx BGJ398 and TAS-120, and of the MEK inhibitor Trametinib. Methods: These studies examined FGFR2-PPHLN1 proteins containing a kinase-dead, kinase-activated, or WT kinase domain in comparison with analogous FGFR2 proteins. Biological activity was assayed using soft agar colony forma- tion in epithelial RIE-1 cells and focus assays in NIH3T3 cells. The MAPK/ERK, JAK/STAT3 and PI3K/AKT signaling pathways were examined for activation. Membrane association was analyzed by indirect immunofluorescence com- paring proteins altered by deletion of the signal peptide, or by addition of a myristylation signal.